FDA Panel Mulls Gene Therapy for Kids With Rare Eye Disease

THURSDAY, Oct. 12, 2017 — A U.S. Food and Drug Administration advisory panel was poised on Thursday to recommend approval for a gene therapy that could grant the gift of sight to young people with a rare type of inherited vision loss.
Replacing a…
Source: Topamax